Key result
Smoking, heavy alcohol, hypertension, diabetes, hypertriglyceridemia, and hyperuricemia are linked to faster arterial stiffness progression.
Why the study?
Increased arterial stiffness does not mediate the cardiovascular risk associated with all cardiovascular risk factors, prompting examination of how the lifelong status of each risk factor associates with progression of arterial stiffness.
Do specific cardiovascular risk factors accelerate the progression of arterial stiffness in middle-aged adults?
Cohort (n=3,763)
Do specific cardiovascular risk factors accelerate the progression of arterial stiffness in middle-aged adults?
Specific cardiovascular risk factors, including smoking, hypertension, and diabetes, but not BMI or LDL-C, independently accelerate the progression of arterial stiffness over a 16-year period.
Supports monitoring modifiable risks to potentially slow stiffness progression; leaves open causal effects and outcome impact in trials.
BACKGROUND: Although some cardiovascular risk factors (CVRFs) are known to be associated with increased arterial stiffness, increased arterial stiffness does not mediate the cardiovascular risk associated with all CVRFs. Here, based on long-term repeated-measurement data, we examined the association of the lifelong status of each CVRF with the rate of progression of arterial stiffness. METHODS: We utilized the data from annual health checkups with the brachial-ankle pulse wave velocity measurements over a 16-year period in middle-aged Japanese occupational cohort. RESULTS: Totally, 29 090 brachial-ankle pulse wave velocity data were obtained during the follow-up of 3763 subjects ranging in age from around 30 to 70 years. Smoking, heavy alcohol intake, hypertension, diabetes, hypertriglyceridemia, and hyperuricemia were independently associated with the fast progression of arterial stiffness. Also, lower values in nondisease range in blood pressure, glycosylated hemoglobin A1c, triglyceride, and uric acid were independently associated with the slow progression of arterial stiffness. For body mass index and low-density lipoprotein cholesterol, no clear associations with the progression of arterial stiffness were observed. CONCLUSIONS: The present prospective study provided more robust epidemiological evidence for the heterogeneity of the significance of contribution of lifelong status of each CVRF to the slow and fast rate of progression of arterial stiffness. These findings suggest the important need to examine, in further studies, the effects of global early interventions to control the levels of the culprit CVRFs, even from middle age, not only to prevent a fast progression of the arterial stiffness but also to maintain a relatively slow progression of arterial stiffness.
No takes yet. Share an insight, caveat, or question.
Tomiyama et al. (2023) conducted a cohort in Arterial stiffness (n=3,763). Cardiovascular risk factors (smoking, heavy alcohol intake, hypertension, diabetes, hypertriglyceridemia, hyperuricemia) vs. Absence of risk factors or lower values in nondisease range was evaluated on Rate of progression of arterial stiffness (brachial-ankle pulse wave velocity). Smoking, heavy alcohol intake, hypertension, diabetes, hypertriglyceridemia, and hyperuricemia were independently associated with the fast progression of arterial stiffness over 16 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: